The Trojan Horse Within: Mechanisms of Immune Evasion in Breast Cancer
Biswajit Das, Charles W. Winterbottom, Shaheen S. Sikandar

TL;DR
This review explores how breast cancer cells evade the immune system and discusses strategies to overcome these evasion mechanisms for better treatment.
Contribution
The paper provides a comprehensive overview of immune evasion mechanisms in breast cancer subtypes and their clinical implications.
Findings
TNBCs expressing PD-L1 show improved responses to immune checkpoint inhibitors.
Tumor heterogeneity and cellular plasticity contribute to immune evasion in breast cancer.
Immune-suppressive cells in the tumor microenvironment help cancer cells avoid detection.
Abstract
Breast cancer (BC) is the most common type of cancer among females, and the number of deaths due to BC has increased over the past few decades. BC is primarily categorized based on the receptor status of BC cells as hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative BC (TNBC). These subtypes differ significantly in their treatment strategies, prognosis, immunogenic nature, and response to immunotherapy. TNBC is the most aggressive with a poor prognosis, but a subset of TNBCs that express programmed cell death ligand 1, have shown promising responses to immune checkpoint inhibitors. Across BC subtypes, distinct immune cell subsets remain active in the tumor immune microenvironment (TIME) that either inhibit or promote the growth of cancer. In isolation, it is challenging for cancer cells to thrive in presence of the body’s…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses · Immune cells in cancer
